Converting a tumor from checkpoint blockade-resistant to checkpoint blockade-sensitive: Immunotransplant for aggressive lymphoma.

e14538Background: Lymphomas comprise the 5thmost common cancers in the U.S. and the majority of these are incurable with standard chemo-immunotherapy, thus, novel, mechanistically distinct therapie...